Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects.

Autor: Aicher HD; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Department of Psychology, University of Zurich, Zurich, Switzerland.; Neuroscience Center Zurich, University of Zurich and ETH, Zurich, Switzerland., Mueller MJ; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Neuroscience Center Zurich, University of Zurich and ETH, Zurich, Switzerland.; Department of Health Science and Technology, ETH, Zurich, Switzerland., Dornbierer DA; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.; Department of Forensic Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland., Suay D; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.; MoMiLab, IMT School for Advanced Studies Luca, Lucca, Italy., Elsner C; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland., Wicki I; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland., Meling D; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Department of Psychosomatic Medicine and Psychotherapy, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Caflisch L; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland., Hempe A; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Biopsychology, Department of Psychology, TUD Dresden University of Technology, Dresden, Germany., Steinhart C; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland., Mueller J; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland., Von Rotz R; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland., Kleim B; Department of Psychology, University of Zurich, Zurich, Switzerland.; Neuroscience Center Zurich, University of Zurich and ETH, Zurich, Switzerland.; Experimental Psychopathology and Psychotherapy, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland., Scheidegger M; Psychedelic Research and Therapy Development, Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland.; Neuroscience Center Zurich, University of Zurich and ETH, Zurich, Switzerland.

Publikováno v: Frontiers in psychiatry [Front Psychiatry] 2024 Jan 08; Vol. 14, pp. 1302559. Date of Electronic Publication: 2024 Jan 08 (Print Publication: 2023).

Reactions of Aqueous L-Methionine, L-Phenylalanine, L-Methionyl-L-Phenylalanine, L-Phenylalanyl-L-Methionine and Their Mixtures with H Atoms during Steady Radiolysis at pH 6.5

Autor: Mee, L. K., Adelstein, S. J., Steinhart, C. M., Lichtin, N. N.

Publikováno v: Radiation Research, 1977 Sep 01. 71(3), 493-504.

Externí odkaz: https://www.jstor.org/stable/3574619

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Prevalence and risk factors of metabolic associated fatty liver disease among people living with HIV in China.

Autor: Liu D; Department of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China., Shen Y; Department of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China., Zhang R; Department of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China., Xun J; Department of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.; Scientific Research Center, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China., Wang J; Department of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China., Liu L; Department of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China., Steinhart C; College of Medicine, The University of Central Florida, Orlando, Florida, USA.; CAN Community Health, Sarasota, Florida, USA., Chen J; Department of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China., Lu H; Department of Infection and Immunity, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.

Publikováno v: Journal of gastroenterology and hepatology [J Gastroenterol Hepatol] 2021 Jun; Vol. 36 (6), pp. 1670-1678. Date of Electronic Publication: 2021 Jan 19.

Predictive Efficacy of Dual Therapies Combining Integrase Strand Transfer Inhibitors with Second-Generation Non-Nucleoside Reverse Transcriptase Inhibitors Following HIV-1 Treatment Failure in Cameroon: Implications for the Use of a Long-Acting Therapeutic Strategy in Low- and Middle-Income Countries

Autor: Gouissi Anguechia, Davy-Hyacinthe^1,2 (AUTHOR) davygouissi@gmail.com, Bouba, Yagai^1,3 (AUTHOR) romeobouba@yahoo.fr, Semengue, Ezechiel Ngoufack Jagni^1,4 (AUTHOR) ezechiel.semengue@gmail.com, Ka'e, Aude Christelle¹ (AUTHOR) kae.audechristelle@gmail.com, Takou, Désiré^1,4 (AUTHOR) dtakou@yahoo.com, Ambe Chenwi, Collins^1,4,5 (AUTHOR) collinschen@yahoo.co.uk, Beloumou, Grace¹ (AUTHOR) graceangong12@yahoo.fr, Nka, Alex Durand¹ (AUTHOR) nkaalexdurand@yahoo.com, Basseck Wome, Ulrich Roland¹ (AUTHOR) freedywilliam@gmail.com, Santoro, Maria Mercedes⁵ (AUTHOR) ceccherini@med.uniroma2.it, Ceccherini-Silberstein, Francesca⁵ (AUTHOR), Chatté, Adawaye⁶ (AUTHOR) cadawaye@yahoo.fr, Montesano, Carla⁷ (AUTHOR) montesan@uniroma2.it, Cappelli, Giulia^8,9 (AUTHOR) giulia.cappelli@cnr.it, Colizzi, Vittorio^1,9,10,11 (AUTHOR) colizzi@bio.uniroma2.it, Ndjolo, Alexis^1,2 (AUTHOR) andjolo@yahoo.com, Mbanya, Dora² (AUTHOR), Ndembi, Nicaise^12,13 (AUTHOR) nicaisen@africa-union.org, Perno, Carlo-Federico^1,14 (AUTHOR) carlofederico.perno@opbg.net, Fokam, Joseph^1,4,15,16 (AUTHOR) nicaisen@africa-union.org

Publikováno v: Viruses (1999-4915). Dec2024, Vol. 16 Issue 12, p1853. 12p.